DIALYSIS · CCN 102624

DaVita Tallahassee Dialysis

TALLAHASSEE, FL 32308

DialysisProfitDaVita
$4.8M
TOTAL REVENUE
16.6%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.8M
Total costs
$4.0M
Operating income (rev − costs)
$798K
Operating margin
16.6%
Total charges
$5.0M
Total treatments
11,656
Dialysis stations
27

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.4150—
Fistula Rate
DFC_FISTULA_RATE
52.4106—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.0139—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
194.296—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.52——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
12106—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
25.2393—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
10.376—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
24.995—
Standardized ED Visits Ratio
DFC_SEDR
1.1732—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
11.729—